Omeros (OMER) Research & Development (2010 - 2026)
Omeros (OMER) reported Research & Development of $13.4 million for Q1 2026, down 43.98% on a YoY basis from $23.8 million in Q1 2025, and down 31.31% sequentially from $19.4 million in Q4 2025.
Omeros (OMER) Research & Development (2010 - 2026) Analysis & Trends
Omeros (OMER) has 17 years of Research & Development data on file, last reported at $13.4 million in Q1 2026.
- For the quarter ending Q1 2026, Research & Development fell 43.98% year-over-year to $13.4 million; the trailing twelve-month figure through Mar 2026 stood at $70.8 million (down 39.27% YoY), and the FY2025 full-year result was $81.3 million, down 31.98% from the prior year.
- Research & Development slipped to $13.4 million in Q1 2026, from $19.4 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $45.3 million in Q2 2024 to a low of $13.4 million in Q1 2026.
- A 5-year average of $26.0 million and a median of $24.1 million in 2022 frame the typical range for Research & Development.
- Across the five-year window, Research & Development soared 53.0% in 2024 and plunged 51.47% in 2025, its largest moves.
- Tracing OMER's Research & Development over 5 years: stood at $26.5 million in 2022, then increased by 8.82% to $28.9 million in 2023, then dropped by 19.28% to $23.3 million in 2024, then dropped by 16.61% to $19.4 million in 2025, then slumped by 31.31% to $13.4 million in 2026.
- Business Quant data shows OMER's Research & Development at $13.4 million in Q1 2026, $19.4 million in Q4 2025, and $16.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -17.94 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 1.46 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 541.22 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 961.60 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 1.54 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 15.66 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -443.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 343.97 Mn |
| 10 | Omeros | 707.67 Mn | 707.67 Mn | 9.31 Mn | 13.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.36 Mn |
| Dec 31, 2025 | 19.45 Mn |
| Sep 30, 2025 | 16.00 Mn |
| Jun 30, 2025 | 22.01 Mn |
| Mar 31, 2025 | 23.85 Mn |
| Dec 31, 2024 | 23.32 Mn |
| Sep 30, 2024 | 24.08 Mn |
| Jun 30, 2024 | 45.35 Mn |
| Mar 31, 2024 | 26.77 Mn |
| Dec 31, 2023 | 28.89 Mn |
| Sep 30, 2023 | 31.73 Mn |
| Jun 30, 2023 | 29.64 Mn |
| Mar 31, 2023 | 24.61 Mn |
| Dec 31, 2022 | 26.55 Mn |
| Sep 30, 2022 | 38.57 Mn |
| Jun 30, 2022 | 23.52 Mn |
| Mar 31, 2022 | 24.09 Mn |
| Dec 31, 2021 | 30.33 Mn |
| Sep 30, 2021 | 25.82 Mn |
| Jun 30, 2021 | 30.13 Mn |